Spots Global Cancer Trial Database for astrocytoma, grade iii
Every month we try and update this database with for astrocytoma, grade iii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes | NCT04304300 | Astrocytoma, Gr... Astrocytoma, Gr... Oligodendroglio... Oligodendroglio... | 18 Years - | Erasmus Medical Center | ||
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | NCT03072134 | Glioma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Brain Cancer | Neural stem cel... | 18 Years - | Northwestern University | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | NCT02655601 | High Grade Glio... Astrocytoma, Gr... Glioblastoma | BMX-001 Radiation Thera... Temozolomide | 18 Years - | BioMimetix JV, LLC | |
| A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma | NCT05765812 | Glioblastoma ID... Astrocytoma, Gr... | Debio 0123 Temozolomide Radiotherapy | 18 Years - | Debiopharm International SA | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma | NCT03224104 | Astrocytoma, Gr... Glioblastoma | TG02 Radiation Thera... Temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma | NCT03224104 | Astrocytoma, Gr... Glioblastoma | TG02 Radiation Thera... Temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | NCT02644291 | Medulloblastoma Astrocytoma, Gr... Glioblastoma Anaplastic Astr... Brain Stem Neop... Oligodendroblas... Anaplastic Olig... Malignant Gliom... | Mebendazole | 1 Year - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma | NCT03906448 | Astrocytoma, Gr... Astrocytoma, Gr... | TTFields with a... | 18 Years - 99 Years | University of Florida | |
| The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | NCT06118723 | Glioblastoma High-grade Glio... Glioblastoma, I... Glioblastoma, I... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Astrocytoma, Ma... Brain Neoplasms Brain Neoplasm,... Brain Neoplasms... Brain Neoplasm,... | Supramaximal re... Maximal safe re... | 18 Years - 90 Years | Erasmus Medical Center | |
| The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | NCT06118723 | Glioblastoma High-grade Glio... Glioblastoma, I... Glioblastoma, I... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Astrocytoma, Ma... Brain Neoplasms Brain Neoplasm,... Brain Neoplasms... Brain Neoplasm,... | Supramaximal re... Maximal safe re... | 18 Years - 90 Years | Erasmus Medical Center | |
| Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma | NCT03224104 | Astrocytoma, Gr... Glioblastoma | TG02 Radiation Thera... Temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | NCT02655601 | High Grade Glio... Astrocytoma, Gr... Glioblastoma | BMX-001 Radiation Thera... Temozolomide | 18 Years - | BioMimetix JV, LLC | |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | NCT02655601 | High Grade Glio... Astrocytoma, Gr... Glioblastoma | BMX-001 Radiation Thera... Temozolomide | 18 Years - | BioMimetix JV, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
